{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:30:50Z","timestamp":1792859450311,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81000468"],"award-info":[{"award-number":["81000468"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81071004"],"award-info":[{"award-number":["81071004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100808"],"award-info":[{"award-number":["81100808"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004602","name":"Program for New Century Excellent Talents in University","doi-asserted-by":"publisher","award":["NCET-04-0288"],"award-info":[{"award-number":["NCET-04-0288"]}],"id":[{"id":"10.13039\/501100004602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","award":["L2010567"],"award-info":[{"award-number":["L2010567"]}],"id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.neurobiolaging.2012.05.009","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T02:20:51Z","timestamp":1340072451000},"page":"562-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":187,"title":["Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Chuang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Yan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ping","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-You","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(03)00174-7","article-title":"Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta","volume":"43","author":"Atwood","year":"2003","journal-title":"Brain Res. Brain Res. Rev"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1471-4159.2000.0751219.x","article-title":"Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1\u201342","volume":"75","author":"Atwood","year":"2000","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2174\/156720510791162403","article-title":"Up-regulation of hypoxia-inducible factor (HIF)-1\u03b1 and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30","volume":"7","author":"Avramovich-Tirosh","year":"2010","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/156720507781788927","article-title":"Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG","volume":"4","author":"Avramovich-Tirosh","year":"2007","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jnr.20864","article-title":"Interleukin-1\u03b1 stimulates non-amyloidogenic pathway by \u03b1-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase","volume":"84","author":"Bandyopadhyay","year":"2006","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neurobiolaging.2004.02.022","article-title":"Secreted beta-amyloid precursor protein activates microglia via JNK and p38-MAPK","volume":"26","author":"Bodles","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-2236(03)00067-5","article-title":"The metallobiology of Alzheimer's disease","volume":"26","author":"Bush","year":"2003","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nurt.2008.05.001","article-title":"Therapeutics for Alzheimer's disease based on the metal hypothesis","volume":"5","author":"Bush","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.arr.2004.01.002","article-title":"Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease","volume":"3","author":"Castellani","year":"2004","journal-title":"Ageing Res. Rev"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ajh.10348","article-title":"Iron chelators for the treatment of iron overload disease: Relationship between structure, redox activity, and toxicity","volume":"73","author":"Chaston","year":"2003","journal-title":"Am. J. Hematol"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib12","doi-asserted-by":"crossref","first-page":"23223","DOI":"10.1074\/jbc.274.33.23223","article-title":"Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion","volume":"274","author":"Cherny","year":"1999","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib13","doi-asserted-by":"crossref","first-page":"31217","DOI":"10.1074\/jbc.M110.149161","article-title":"Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1","volume":"285","author":"Cho","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib14","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","article-title":"Intramuscular desferrioxamine in patients with Alzheimer's disease","volume":"337","author":"Crapper McLachlan","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00966731","article-title":"Effects of chelators on iron uptake and release by the brain in the rat","volume":"19","author":"Crowe","year":"1994","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jn\/126.1.183","article-title":"Iron and copper interact during their uptake and deposition in the brain and other organs of developing rats exposed to dietary excess of the two metals","volume":"126","author":"Crowe","year":"1996","journal-title":"J. Nutr"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1749-6632.2000.tb06938.x","article-title":"Metal chelation as a potential therapy for Alzheimer's disease","volume":"920","author":"Cuajungco","year":"2000","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib18","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.neurobiolaging.2007.02.006","article-title":"Reversion of age-related recognition memory impairment by iron chelation in rats","volume":"29","author":"De Lima","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib20","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.2111583","article-title":"Cleavage of amyloid beta peptide during constitutive processing of its precursor","volume":"248","author":"Esch","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1020799512190","article-title":"The copper-iron chronicles: the story of an intimate relationship","volume":"16","author":"Fox","year":"2003","journal-title":"Biometals"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0300-483X(88)90010-8","article-title":"Neurotoxicity associated with deferoxamine therapy","volume":"49","author":"Freedman","year":"1988","journal-title":"Toxicology"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10717549709051878","article-title":"Delivery of 125I-NGF to the brain via the olfactory route","volume":"4","author":"Frey","year":"1997","journal-title":"Drug Deliv"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/41343","article-title":"Cloning and characterization of a mammalian proton-coupled metal-ion transporter","volume":"388","author":"Gunshin","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/357500a0","article-title":"Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments","volume":"357","author":"Haass","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neulet.2004.12.080","article-title":"A role for hypoxia-inducible factor-1alpha in desferoxamine neuroprotection","volume":"379","author":"Hamrick","year":"2005","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-011-0050-2","article-title":"Intranasal delivery of deferoxamine reduces spatial memory loss in APP\/PS1 mice","author":"Hanson","year":"2012","journal-title":"Drug Deliv. Transl. Res"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/jpet.108.149807","article-title":"Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke","volume":"330","author":"Hanson","year":"2009","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-2004-6310","article-title":"Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease","volume":"6","author":"House","year":"2004","journal-title":"J. Alzheimers Dis"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib32","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.1021\/bi900907a","article-title":"Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease","volume":"48","author":"Jiang","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1083\/jcb.200301115","article-title":"APP processing is regulated by cytoplasmic phosphorylation","volume":"163","author":"Lee","year":"2003","journal-title":"J. Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuroimage.2010.11.073","article-title":"Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease","volume":"5","author":"Leskovjan","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib35","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ijc.2910630421","article-title":"Influence of hepatic artery occlusion and desferrioxamine on liver-tumour growth","volume":"63","author":"Lindn\u00e9r","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer's disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J. Neurol. Sci"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3233\/JAD-2004-6610","article-title":"Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3","volume":"6","author":"Lovell","year":"2004","journal-title":"J. Alzheimers Dis"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0079-6468(08)70220-0","article-title":"The present status of chelating agents in medicine","volume":"20","author":"May","year":"1983","journal-title":"Prog. J. Med. Chem"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10571-009-9401-7","article-title":"Chronic exposure to high levels of zinc or copper has little effect on brain metal homeostasis or Abeta accumulation in transgenic APP-C100 mice","volume":"29","author":"Maynard","year":"2009","journal-title":"Cell. Mol. Neurobiol"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4155\/fmc.09.140","article-title":"Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders","volume":"2","author":"Mills","year":"2010","journal-title":"Future. J. Med. Chem"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tox.2011.11.003","article-title":"Deferoxamine pretreatment prevents Cr(VI)-induced nephrotoxicity and oxidant stress: Role of Cr(VI) chelation","volume":"291","author":"Molina-Jij\u00f3n","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-1-60327-029-8_25","article-title":"Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease","volume":"610","author":"Moreira","year":"2010","journal-title":"Methods Mol. Biol"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1385\/JMN:24:1:129","article-title":"FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein","volume":"24","author":"Morse","year":"2004","journal-title":"J. Mol. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib44","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1249\/00005768-199305000-00006","article-title":"Effects of iron supplementation and discontinuation on serum copper, zinc, calcium and magnesium levels in women","volume":"25","author":"Newhouse","year":"1993","journal-title":"Med. Sci. Sports Exer"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/156720210790820172","article-title":"Iron leads to memory impairment that is associated with a decrease in acetylcholinesterase pathways","volume":"7","author":"Perez","year":"2010","journal-title":"Curr. Neurovasc Res"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9343(00)00547-7","article-title":"Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease","volume":"109","author":"Pratic\u00f2","year":"2000","journal-title":"Am. J. Med"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/jmg.2003.015552","article-title":"Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease","volume":"41","author":"Robson","year":"2004","journal-title":"J. Med. Genet"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib48","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1042\/BST0361282","article-title":"Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease","volume":"36","author":"Rogers","year":"2008","journal-title":"Biochem. Soc. Trans"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib49","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2174\/1389450043345272","article-title":"Metal and inflammatory targets for Alzheimer's disease","volume":"5","author":"Rogers","year":"2004","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib50","doi-asserted-by":"crossref","first-page":"45518","DOI":"10.1074\/jbc.M207435200","article-title":"An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript","volume":"277","author":"Rogers","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib51","first-page":"209","article-title":"Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease","volume":"19","author":"Savory","year":"1998","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib52","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2174\/0929867013372922","article-title":"Chemistry and biochemistry of oxidative stress in neurodegenerative disease","volume":"8","author":"Sayre","year":"2001","journal-title":"Curr. Med. Chem"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00109-006-0140-7","article-title":"Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels","volume":"85","author":"Sch\u00e4fer","year":"2007","journal-title":"J. Mol. Med"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib54","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer's disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib55","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuropharm.2003.09.005","article-title":"Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lesion in rats","volume":"46","author":"Shachar","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib56","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1439760","article-title":"Production of the Alzheimer amyloid beta protein by normal proteolytic processing","volume":"258","author":"Shoji","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib57","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1046\/j.1471-4159.1998.70052212.x","article-title":"Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress","volume":"70","author":"Smith","year":"1998","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0031-9384(95)02030-6","article-title":"Neurobehavioral dysfunctions associated with dietary iron overload","volume":"59","author":"Sobotka","year":"1996","journal-title":"Physiol. Behav"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib59","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neurobiolaging.2007.10.012","article-title":"Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid","volume":"30","author":"Strozyk","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib60","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nbd.2005.10.013","article-title":"Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease","volume":"22","author":"El Tannir El Tayara","year":"2006","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib61","doi-asserted-by":"crossref","first-page":"51958","DOI":"10.1074\/jbc.M407410200","article-title":"Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's disease","volume":"279","author":"Treiber","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10284150701350653","article-title":"Iron regulation in C57BLI6 and DBA\/2 mice subjected to iron overload","volume":"10","author":"Unger","year":"2007","journal-title":"Nutr. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1332.003","article-title":"The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region","volume":"1035","author":"Venti","year":"2004","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/nbdi.1999.0250","article-title":"The role of copper in neurodegenerative disease","volume":"6","author":"Waggoner","year":"1999","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib66","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1326-5-46","article-title":"Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model","volume":"5","author":"Wang","year":"2010","journal-title":"Mol. Neurodegener"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib67","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.spen.2006.08.008","article-title":"Iron: a new target for pharmacological intervention in neurodegenerative diseases","volume":"13","author":"Whitnall","year":"2006","journal-title":"Semin. Pediatr. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib68","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0378-4274(95)03532-X","article-title":"Toxicity of iron and hydrogen peroxide: the Fenton reaction","volume":"82\u201383","author":"Winterbourn","year":"1995","journal-title":"Toxicol. Lett"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib69","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1079\/BJN19940194","article-title":"Increasing intakes of iron reduce status, absorption and biliary excretion of copper in rats","volume":"71","author":"Yu","year":"1994","journal-title":"Br. J. Nutr"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib70","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrn1537","article-title":"Iron, brain ageing and neurodegenerative disorders","volume":"5","author":"Zecca","year":"2004","journal-title":"Nat. Rev. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib71","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2008.02.018","article-title":"Altered expression and distribution of zinc transporters in APP\/PS1 transgenic mouse brain","volume":"31","author":"Zhang","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib72","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1096\/fj.09-135749","article-title":"Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation","volume":"23","author":"Zheng","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.neurobiolaging.2012.05.009_bib73","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiol.2532082324","article-title":"Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease","volume":"253","author":"Zhu","year":"2009","journal-title":"Radiology"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:20:40Z","timestamp":1759317640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458012002965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0197458012002965"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.05.009","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}